Contact Us

Pulmonary Embolism
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Please describe blood clots:

If you believe the blood clots developed as the result of a drug, please list drug:

Please describe your case:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Pulmonary Embolism


Facebook Twitter Stumble AddThis Social Bookmark Button Pin It Email to Friend Print Page

Pulmonary Embolism (PE) Disease Injury Lawsuits

Pulmonary Embolism (PE) | Lawsuits, Lawyers | Disease: Injury, Infection | Side Effects, Prescription Drugs, Medications, HRT drugs; COX-II Inhibitors, Ortho Evra Patch

On November 10, 2005, Johnson & Johnson issued a warning about its Ortho Evra birth control patch causing a higher incidence of blood clots than oral contraceptives. A Pulmonary Embolism is a blood clot that passes from the legs to the lungs.

The AP reported that, based upon FDA records it obtained through a Freedom of Information Act, women using Ortho Evra in 2004 were three (3) times more likely then women using birth control pills to die or develop nonfatal blood clots. The Associated Press learned that of the 23 cases in which death was the outcome, doctors reviewing the cases found 17 that appeared to be blood-clot-related, including 12 in 2004.

Additionally, in The October 12, 1996, issue of the Lancet contains three articles and a letter reporting that current users of postmenopausal hormone replacement therapy (HRT) drugs (Prempro, Premarin, and Premphase) may have a twofold or higher increased risk of deep vein thrombosis (DVT) in the legs and may lead to Pulmonary embolism (PE).

Patients who take or have taken Vioxx are at an increased risk of developing pulmonary embolism (PE). Vioxx promotes the formation of blood clots, which can later cause a pulmonary embolism (PE). Merck & Co. removed its blockbuster arthritis drug Vioxx from the market worldwide because new data from a clinical trial found an increased risk of heart attack and stroke.

Merck decided to remove the drug from the market on September 30, 2004, after data from the trial showed an increased risk of heart attack, stroke, blood clots and other cardiovascular complications.

A pulmonary embolism (PE) is a blood clot in the lung. It usually comes from smaller vessels in the leg, pelvis, arms, or heart. When a clot forms in the legs or arms, it is referred to as a deep venous thrombosis (DVT).

The clot passes through the vessels of the lung continuing to reach smaller vessels until it becomes wedged in a vessel that is too small to allow it to continue anymore. The clot gets wedged and prevents any further blood from traveling to that section of the lung.

There are numerous factors that may make someone more likely to develop a blood clot that can sooner or later break loose and travel to the lung:

1) Immobilization: A stroke, broken bone, or spinal cord injury can result in confinement to bed so that clot formation can occur in either the arms or legs.

2) Travel: Prolonged travel, such as sitting in an airplane or a long car trip, allows the blood to sit in the legs and increases the risk of clot formation.

3) Trauma or injury (especially to the legs).

4) Obesity.

5) Heart disease (such as an irregular heartbeat).

6) Burns.

7) Previous history of blood clot in the legs (DVT) or Pulmonary embolism.

Conditions that increase clotting of the blood:

1) Pregnancy

2) Cancer

3) Certain protein and enzyme deficiencies

4) Hormone Replacement Therapy (HRT) drugs

Legal Help For Victims Affected By Pulmonary Embolism (PE)

If you or a loved one has taken HRT drugs; COX-II Inhibitors, or the Ortho Evra Patch and were diagnosed with a Pulmonary Embolism (PE), please fill out the form at the right for a free case evaluation by a qualified defective drug attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).

Pulmonary EmbolismRSS Feed

Exclusive: Women Claim Birth Control Patchs' Risks Undisclosed

Feb 8, 2007 | www.thedenverchannel.com
More than 4 million women use the birth control patch, but the patch may hold risks for some women who use it, risks they may not be aware of. A number of women told 7NEWS that the patch ruined their lives. They all made the choice to use the patch because they said they were told it was just as safe as other birth control. Six Colorado women said they believe they were victims of a corporate secret. Three of the women had pulmonary embolisms and three had blood clots. All six said they never...

Parker & Waichman, LLP Files 100th Lawsuit Against Ortho-McNeil Pharmaceutical, Inc.; Case Filed on Behalf of 26 Year Old Woman who Suffered Pulmonary Embolism after Using the Birth Control Patch for 9 Months

Nov 6, 2006 | www.webwire.com
Parker & Waichman, LLP (www.yourlawyer.com) announced that it has filed a lawsuit against Ortho McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 26 year-old woman. The suit, which was filed last week in the Superior Court of New Jersey, Law Division, Middlesex County, was the 100th lawsuit filed by Parker & Waichman, LLP on behalf of Ortho Evra victims. Parker & Waichman, LLP has been retained by hundreds of additional women who were...

Parker & Waichman, LLP Files Lawsuit Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of Ortho Evra Victim - JNJ

Sep 19, 2006 | PrimeZone
Parker & Waichman, LLP (www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 25 year-old woman. The woman was diagnosed with bilateral pulmonary emboli after using the Ortho Evra birth control patch for six months. The suit was filed in the Superior Court of New Jersey, Law Division, Middlesex County (midl-8005-06), earlier this month. Parker & Waichman, LLP continues to evaluate...

Parker & Waichman, LLP Files Suit Against Ortho-McNeil Pharmaceutical, Inc., Additional Suits to be Filed in Coming Months - JNJ

Aug 24, 2006 | PrimeZone
Parker & Waichman, LLP (www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 34 year-old woman. The woman was diagnosed with a severe pulmonary embolism after using the Ortho Evra birth control patch less than two years. The suit was filed in the United States District Court for the District of New Jersey earlier this month. Additionally, Parker & Waichman, LLP announced that it...

Parker & Waichman, LLP Files Suit Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of Estate of 26-Year-Old Woman Who Died After Using Ortho Evra for 7-1/2 Months - JNJ

Jul 13, 2006 | PrimeZone
Parker & Waichman, LLP (www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of the estate of a 26-year-old woman. The decedent died from an acute pulmonary embolism after using the Ortho Evra birth control patch from November 26, 2002 to July 8, 2003. The suit was filed in the United States District Court for the Eastern District of Michigan. For more information on Ortho Evra and this...

More Pulmonary Embolism News

Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo Protected by Copyscape Web Copyright Protection Software php-5